Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.17p
   
  • Change Today:
    -0.045p
  • 52 Week High: 2.61
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 362,110
  • Market Cap: £4.86m
  • RiskGrade: 328
  • Beta: 0.70

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
16-Apr-18 Berenberg Bank Buy 147.00p 1,200.00p 1,200.00p Reiteration
23-Mar-18 Northland Capital Partners Buy 125.50p - 181.00p Reiteration
21-Dec-17 FinnCap Buy 150.00p 237.00p 237.00p Reiteration
30-Apr-15 Panmure Gordon Buy - 150.00p 150.00p Reiteration
12-Mar-12 Peel Hunt Limited Sell - - 50.00p New Coverage
21-Nov-11 Sanlam Securities Buy - - 323.00p New Coverage
06-Dec-10 Espirito Santo Execution Buy - 200.00p - Reiteration
30-Sep-10 Singer Capital Markets Buy - - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.17p
Change Today -0.045p
% Change -3.71 %
52 Week High 2.61
52 Week Low 0.85
Volume 362,110
Shares Issued 416.44m
Market Cap £4.86m
Beta 0.70
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.09% below the market average69.09% below the market average69.09% below the market average69.09% below the market average69.09% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Trend
71.01% below the market average71.01% below the market average71.01% below the market average71.01% below the market average71.01% below the market average
44% below the sector average44% below the sector average44% below the sector average44% below the sector average44% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 09-Dec-2024

Time Volume / Share Price
16:25 41,018 @ 1.12p
16:11 29,062 @ 1.12p
16:09 41,562 @ 1.20p
16:07 15,297 @ 1.17p
16:06 5,578 @ 1.12p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page